---
figid: PMC9354686__fonc-12-934711-g006
figtitle: Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC9354686
filename: fonc-12-934711-g006.jpg
figlink: /pmc/articles/PMC9354686/figure/f6/
number: F6
caption: Possible oncogenic role of miR-217. In cancer transition one (stage I–II),
  miR-217 allows GALNTL6 overexpression. This protein typically initiates post-translational
  modifications in the Golgi apparatus. Additionally, in cell culture models, these
  enzymes affect the ER via aberrant Src signaling. In stages II–III (transition two),
  miR-217 represses WNK2 expression, a tumor suppressor which inhibits cell proliferation
  by negatively modulating the activation of the MEK1 pathway. In the last transition
  (stages III–IV), miR-217 enables IGF2BP2 overexpression. This gene promotes tumor
  progression in several types of cancer, such as glioblastoma multiforme and gallbladder
  cancer. IGF2BP2 also promotes tumor cell proliferation through the PI3K-Akt pathway
  ().
papertitle: Oncogenic Role of miR-217 During Clear Cell Renal Carcinoma Progression.
reftext: Jose María Zamora-Fuentes, et al. Front Oncol. 2022;12:934711.
year: '2022'
doi: 10.3389/fonc.2022.934711
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: clear cell renal carcinoma | gene co-expression networks | WKN2 | GALNTL6
  | IGF2BP2 | miR-217 | cancer progression stages | renal carcinoma progression
automl_pathway: 0.9547758
figid_alias: PMC9354686__F6
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9354686__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9354686__fonc-12-934711-g006.html
  '@type': Dataset
  description: Possible oncogenic role of miR-217. In cancer transition one (stage
    I–II), miR-217 allows GALNTL6 overexpression. This protein typically initiates
    post-translational modifications in the Golgi apparatus. Additionally, in cell
    culture models, these enzymes affect the ER via aberrant Src signaling. In stages
    II–III (transition two), miR-217 represses WNK2 expression, a tumor suppressor
    which inhibits cell proliferation by negatively modulating the activation of the
    MEK1 pathway. In the last transition (stages III–IV), miR-217 enables IGF2BP2
    overexpression. This gene promotes tumor progression in several types of cancer,
    such as glioblastoma multiforme and gallbladder cancer. IGF2BP2 also promotes
    tumor cell proliferation through the PI3K-Akt pathway ().
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mir217
  - Ppp1r2
  - Galntl6
  - Wnk2
  - Igf2bp2
  - Igf2
  - D7Zem1
  - D7Zem3
  - D7Zem2
  - MIR217
  - GALNTL6
  - WNK2
  - IGF2BP2
  - IGF2
---
